NovoCure Limited (NVCR) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.72B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-3.42M; Retained Earnings (Accumulated Deficit)USD $-1.38B.
- 2026-03-31: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.70B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.89M; Retained Earnings (Accumulated Deficit)USD $-1.36B.
- 2025-12-31: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.63B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-3.44M; Retained Earnings (Accumulated Deficit)USD $-1.29B.
- 2025-09-30: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $1.61B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.81M; Retained Earnings (Accumulated Deficit)USD $-1.27B.
NovoCure Limited Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.72B | $-3.42M | $-1.38B | $338.09M | 3 month · $17.01M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $1.70B | $-4.89M | $-1.36B | $330.72M | 3 month · $63.01M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $1.63B | $-3.44M | $-1.29B | $340.47M | 12 month · $104.83M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $1.61B | $-5.81M | $-1.27B | $341.33M | 3 month · $29.32M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $1.58B | $-5.11M | $-1.23B | $349.44M | 3 month · $26.14M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $1.55B | $-4.20M | $-1.19B | $361.96M | 3 month · $29.55M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $1.52B | $-5.50M | $-1.15B | $360.18M | 12 month · $160.03M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $1.45B | $-5.38M | $-1.09B | $360.78M | 3 month · $31.36M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $1.42B | $-3.52M | $-1.06B | $361.75M | 3 month · $31.83M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $1.39B | $-4.15M | $-1.02B | $359.36M | 3 month · $34.08M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $1.35B | $-5.47M | $-985.50M | $362.50M | 12 month · $115.61M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $1.33B | $-1.99M | $-938.42M | $393.70M | 3 month · $26.35M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $1.31B | $-1.98M | $-888.94M | $415.68M | 3 month · $32.74M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $1.27B | $-2.69M | $-831.52M | $432.15M | 3 month · $39.08M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $1.22B | $-2.43M | $-778.46M | $441.17M | 12 month · $106.95M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $1.19B | $-2.31M | $-741.16M | $445.40M | 3 month · $26.30M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $1.16B | $-2.10M | $-714.58M | $441.67M | 3 month · $25.82M | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $1.13B | $-1.33M | $-690.57M | $435.88M | 3 month · $25.05M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $1.10B | $-3.17M | $-685.93M | $410.49M | 12 month · $94.90M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $1.07B | $-900.00K | $-659.47M | $413.16M | 3 month · $25.76M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $1.04B | $-1.12M | $-646.34M | $397.27M | 3 month · $27.88M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $1.01B | $-1.95M | $-631.70M | $372.13M | 3 month · $18.86M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $1.11B | $-3.83M | $-631.08M | $476.53M | 12 month · $75.72M | (m) | 12 month · $132.47M | (m) | (m) |
| 2020-09-30 | $0.00 | $946.27M | $-3.24M | $-635.99M | $307.04M | 3 month · $20.12M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $916.63M | $-3.53M | $-645.28M | $267.82M | 3 month · $18.77M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $892.51M | $-3.63M | $-646.93M | $241.95M | 3 month · $16.56M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $871.44M | $-2.77M | $-650.88M | $217.79M | 12 month · $52.42M | (m) | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $848.15M | $-2.64M | $-655.14M | $190.37M | 3 month · $14.34M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $818.34M | $-2.36M | $-657.08M | $158.91M | 3 month · $13.73M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $783.94M | $-1.74M | $-655.80M | $126.39M | 3 month · $9.65M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $757.31M | $-1.40M | $-643.65M | $112.26M | 12 month · $39.85M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | $744.09M | $-1.13M | $-628.02M | $114.94M | 3 month · $10.48M 9 month · $29.20M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $729.68M | $-1.27M | $-616.33M | $112.08M | 3 month · $10.21M 6 month · $18.73M | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $708.27M | $-1.33M | $-600.82M | $106.12M | 3 month · $8.52M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $697.16M | $-1.34M | $-582.26M | $113.56M | 12 month · $27.12M | (m) | (m) | (m) | 12 month · $0.00 |
| 2017-09-30 | $0.00 | $689.46M | $-1.46M | $-571.31M | $116.69M | 9 month · $20.76M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $679.10M | $-1.74M | $-559.82M | $117.55M | 6 month · $12.13M | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $669.46M | $-1.92M | $-538.64M | $128.90M | 3 month · $4.56M | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $664.15M | $-1.88M | $-519.93M | $142.34M | 12 month · $21.44M | (m) | (m) | (m) | 12 month · $698.00K |
| 2016-09-30 | $0.00 | $658.09M | $-2.08M | $-497.76M | $158.24M | 9 month · $16.72M | (m) | (m) | (m) | (m) |
| 2016-06-30 | $0.00 | $652.46M | $-1.68M | $-464.13M | $186.65M | 6 month · $11.09M | (m) | (m) | (m) | (m) |
| 2016-03-31 | $0.00 | $645.92M | $-1.98M | $-423.52M | $220.43M | 3 month · $5.46M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $640.41M | $-1.50M | $-388.08M | $250.82M | 12 month · $11.86M | $0.00 | (m) | (m) | (m) |
| 2015-09-30 | $0.00 | $476.38M | (m) | $-355.15M | $121.22M | 9 month · $7.37M | $0.00 | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | $374.38M | $0.00 | $-276.50M | $97.88M | 12 month · $4.62M | $0.00 | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $171.78M | 12 month · $5.12M | (m) | (m) | 12 month · $2.86M | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $49.42M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |